Report full data readout from the Phase 1 AdCOVID clinical study
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- 29 Jun 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Altimmune anticipates having a full data readout from this Phase 1 study in Q2 2021.”
What we found
Evidence strength A What the grades mean
Altimmune announced on June 29, 2021 that it had reviewed Phase 1 AdCOVID findings and discontinued the program, indicating the readout occurred within Q2 2021.
-
A Altimmune, Inc. 10-Q filed 2021-08-10
“On June 29, 2021, the Company announced the discontinuation of the development program for the COVID-19 vaccine candidate, AdCOVID following the Company’s review of findings from the Phase 1 clinical trial” ✓ confirmed on the page
-
A Altimmune, Inc. 10-Q filed 2021-11-09
“the immunogenicity data demonstrated lower than expected immune responses for each of the immune parameters tested” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Phase 1 AdCOVID full data readout
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Altimmune, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ALT-024614 · Corrections policy